Related Experiment Video
Updated: Jun 2, 2026

Activity-based Training on a Treadmill with Spinal Cord Injured Wistar Rats
Published on: January 16, 2019
Effects of a 12-week aerobic training on TLQP-21, its receptor, and UCP1 in STZ-induced diabetic Wistar rats
Pourya Foroutan1, Juan L López2, Fallah Mohammadi3
1Faculty of Sport Sciences, University of Mazandaran, Babolsar, Iran; Department of Physiology, Faculty of Medicine, Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain.
Introduction:
Type 2 diabetes (T2DM) is marked by insulin resistance and impaired insulin production, with lifestyle interventions like exercise playing a key role in its management. TLQP-21, a vgf-derived peptide, and its receptor, C3AR1, are involved in regulating energy balance, insulin secretion, and inflammation.
Methods:
This study investigated the effects of a 12-week aerobic exercise intervention on TLQP-21/C3AR1 signaling in diabetic and non-diabetic Wistar rats. Animals were divided into four groups: Control (CG), Diabetic (DG), Exercise (EG), and Diabetic + Exercise (DEG). Diabetes was induced using a high-fat diet combined with streptozotocin (STZ) injection. Exercise training was implemented for 12 weeks, and tissues were collected for molecular and histological analysis.
Results:
vgf mRNA expression did not change significantly in all tissues. However, TLQP-21 protein levels increased mainly in brown adipose tissue (BAT) and pancreas (PAN), particularly under diabetic and exercise conditions. Diabetes altered c3ar1 expression in a tissue-specific manner, decreasing hypothalamic (HPT) c3ar1 mRNA while increasing PAN c3ar1 mRNA and protein levels. Exercise attenuated diabetes-associated c3ar1 changes and also increased BAT UCP1 protein level. Exercise also improved BAT morphology by reducing brown adipocyte (BA) size and increasing BA and Mitochondria (MT) abundance.
Conclusion:
These findings suggest that exercise was associated with improved diabetic metabolic dysfunction by modulating TLQP-21/C3AR1 signaling, enhancing UCP1 expression, BAT remodeling, and mitochondrial abundance in rats, highlighting its therapeutic potential in managing metabolic dysfunctions associated with T2DM.
